Structural investigation of Keap1–Nrf2 protein–protein interaction (PPI) inhibitors for treating myocarditis through molecular simulations
- 30 March 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (18) , 8524-8537
Abstract
Myocarditis is classified as an inflammatory disease of the heart muscle and is a leading cause of sudden death. The Keap1-Nrf2-ARE pathway is an important antioxidant defense mechanism that protects cells from oxidative stress and the Keap1-Nrf2 protein–protein interaction (PPI) is considered as a potential drug target against myocarditis to upregulate the expression of ARE-controlled cytoprotective oxidative stress response enzymes. To gain insights into the relationship between the activity and structure of the compounds and design superior active novel inhibitors, 3D-QSAR, molecular docking and molecular dynamics (MD) simulation were combined to investigate the interaction between Keap1–Nrf2 PPI inhibitors and Keap1. The comparative molecular field analysis (CoMFA) model (q2 = 0.907, n = 7, R2 = 0.997) and the comparative molecular similarity index analysis (CoMSIA) model (q2 = 0.900, n = 7, and R2 = 0.993) showed that the 3D-QSAR models built were credible and predictable. Based on these models, 10 new compounds were discovered and their bioactivity was validated using molecular docking and MD simulation. Furthermore, the plausible ADME/T characteristics of new compounds were evaluated and the key residues (Arg415, Tyr334, Ser602, Ser363, Arg380, etc.) in the active site were also identified by free energy calculation. The binding energy results show that the structurally optimized compounds (N1: −65.409 kcal mol−1, N3: −54.619 kcal mol−1, N4: −62.627 kcal mol−1, N5: −60.903 kcal mol−1, and N8: −66.272 kcal mol−1) have lower binding free energy values than compound 43 (ΔGbind: −49.991 kcal mol−1), indicating that they have a better affinity for the target. These findings provide necessary theoretical guidance for the discovery and design of highly active drugs against myocarditis.Keywords
Funding Information
- Chongqing University of Technology (gzlcx20223349)
- Natural Science Foundation of Chongqing Municipality (CSTB2022NSCQ-MSX1327)
- Chongqing Municipal Education Commission
This publication has 57 references indexed in Scilit:
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh EwaldJournal of Chemical Theory and Computation, 2013
- Quantitative Studies on Structure-DPPH• Scavenging Activity Relationships of Food Phenolic AcidsMolecules, 2012
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized BornJournal of Chemical Theory and Computation, 2012
- Identification of Novel HIV‐1 Integrase Inhibitors Using Shape‐Based Screening, QSAR, and Docking ApproachChemical Biology & Drug Design, 2012
- Peptide inhibitors of the Keap1–Nrf2 protein–protein interactionFree Radical Biology and Medicine, 2012
- Discovery of the Negative Regulator of Nrf2, Keap1: A Historical OverviewAntioxidants & Redox Signaling, 2010
- Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics SimulationsJournal of Chemical Information and Modeling, 2010
- 3D-QSAR and Molecular Docking Studies on Derivatives of MK-0457, GSK1070916 and SNS-314 as Inhibitors against Aurora B KinaseInternational Journal of Molecular Sciences, 2010
- Structural Basis for Dimerization in DNA Recognition by Gal4Structure, 2008
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004